tiprankstipranks
Blurbs

Jefferies Sticks to Their Buy Rating for AdaptHealth (AHCO)

Jefferies analyst Brian Tanquilut maintained a Buy rating on AdaptHealth (AHCOResearch Report) today and set a price target of $35.00. The company’s shares closed yesterday at $21.94.

According to TipRanks, Tanquilut is a 4-star analyst with an average return of 4.6% and a 53.25% success rate. Tanquilut covers the Healthcare sector, focusing on stocks such as Amedisys, Acadia Healthcare, and Community Health.

Currently, the analyst consensus on AdaptHealth is a Strong Buy with an average price target of $29.67, which is a 35.23% upside from current levels. In a report released on January 11, Robert W. Baird also maintained a Buy rating on the stock with a $31.00 price target.

See today’s best-performing stocks on TipRanks >>

The company has a one-year high of $27.48 and a one-year low of $11.40. Currently, AdaptHealth has an average volume of 775K.

Based on the recent corporate insider activity of 61 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of AHCO in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

AdaptHealth Corp. provides medical products for both rental and sale. It focuses on respiratory and/or mobility equipment, including CPAP sleep equipment, oxygen equipment, wheelchairs, walkers, and hospital beds. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.

Read More on AHCO:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles